NCT00238511View on ClinicalTrials.gov

An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN)

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2002

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
Postherpetic Neuralgia
Interventions
DRUG

SPM 927

Trial Locations (1)

Unknown

Schwarz, Monheim

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY